Cormorant Asset Management »

Mestera shares owned by Cormorant Asset Management

Quarter-by-quarter ownership of Mestera (MTSR) shares owned by Cormorant Asset Management from 13F filings

Historical chart of Cormorant Asset Management investment in Mestera

Tip: Access up to 7 years of quarterly data

All positions including Mestera held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mestera by Cormorant Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $21M 400k 52.33
2025-06-30 $11M 400k 28.45
2025-03-31 $11M 400k 27.22

More positions owned by Cormorant Asset Management

Bridgebio Oncology Therapeut Com New
Abivax Sa Sponsored Ads (ABVX)
Eyepoint Pharmaceuticals Com New (EYPT)
Rapport Therapeutics (RAPP)
Bridgebio Pharma (BBIO)
Edgewise Therapeutics (EWTX)
Bright Minds Biosciences Com New (DRUG)
Arcellx Common Stock (ACLX)
Insmed Com Par $.01 (INSM)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Praxis Precision Medicines I Com New (PRAX)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Pharvaris N V (PHVS)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Gh Research Ordinary Shares (GHRS)

View all positions for Cormorant Asset Management

Top funds holding Mestera

FMR
Vanguard Group
Henderson Group
BlackRock
Alphabet
VR Adviser
Wellington Management Company
Softbank Group Corp
State Street Corporation
Falcon Edge Capital
T. Rowe Price Investment Management
Geode Capital Management
RA Capital Management
Susquehanna International
Charles Schwab Investment Management

View all funds holding Mestera